CancerInfo Center

Battling Cancer In Cuba
Hugo Chavez, the president of Venezuela, is fighting for his life. Whatever kind of cancer he has is roaring back to life. He’s currently in Havana, Cuba for surgery.
Drug May Reduce Cancer Spread to Bone
Patients with advanced prostate cancer may have cancer cells that spread to the bone and cause pain. A new drug shows promise by rapidly reducing prostate cancer bone tumors.
The Net Around Head and Neck Cancers
Cancer that occurs in linings of the mouth, throat and nose are called head and neck cancers. The incidence of these cancers is on the rise. People who smoke and drink are at high risk.
Influx of Bad Acid Reflux in England
First there's the heartburn. And maybe nausea. It's common among people with acid reflux and, across the UK, more are letting it become a bigger problem.
Roundworm-Eating Fungus May Kill Cancer
A lowly flesh-eating fungus that feasts on a diet of roundworms may have a higher purpose. Tiny particles produced by the fungus may be able to stimulate the immune system and stop cancer.
New Option For Late-Stage Prostate Cancer
Men with castration-resistant prostate cancer have another treatment option. The US Food and Drug Administration (FDA) has approved the expanded use of Zytiga (abiraterone acetate).
End Caps and Pancreatic Cancer
Trying to predict who’s at risk for cancer is a key research goal. Scientists look at all sorts of things to do this. Science is making progress in predicting pancreatic cancer risk.
Self-Injury in Kids of Cancer Patients
Coping with the loss of a parent to cancer during the teen years can be too much to handle. Inflicting self-harm or thinking or attempting suicide is far too common for this group.
Colorectal Cancer May Be Just A Breath Away
Of all the screenings, looking for colorectal cancer is one of the most dreaded. That’s because the most effective tests are invasive and uncomfortable. Work is underway to bring a breath of fresh air to the process.
One Equals More Than Two
Herceptin is the standard medication for treating HER2-positive breast cancer. There has been some question about how long this treatment should last. A new study has answered that question.